Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | MET | P08581 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | BCL2 | P10415 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6830586 | 0.82 | NPC1 (0.47) | CNR2FAAHNPC1RAB9AMAPT | |
| SCHEMBL6835632 | 0.78 | TRPA1 (0.39) | MAPTMEN1TSHRKMT2AHSD17B10 | |
| SCHEMBL6814917 | 0.77 | AKR1C2 (0.48) | MAPTAKR1C2AKR1C1BCL2MCL1 | |
| SCHEMBL6819126 | 0.75 | HSD17B10 (0.48) | NPC1RAB9AMAPTMEN1TSHR | |
| SCHEMBL6818312 | 0.74 | HSD17B10 (0.45) | CNR2NPC1RAB9AMAPTMEN1 | |
| SCHEMBL6818318 | 0.74 | CNR2 (0.56) | CNR2FAAHNPC1RAB9AMAPT | |
| SCHEMBL6833783 | 0.74 | HSD17B10 (0.49) | NPC1RAB9AMAPTMEN1TSHR | |
| SCHEMBL6818527 | 0.74 | CNR2 (0.56) | CNR2FAAHNPC1RAB9AMEN1 | |
| SCHEMBL6818638 | 0.73 | KDM4E (0.50) | NPC1RAB9AMAPTMEN1TSHR | |
| SCHEMBL6817920 | 0.73 | HSD17B10 (0.46) | CNR2FAAHNPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | CNR2 3495/4885FAAH 737/4885MET 3718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.